Associate Research Scientist

The Department of Systems Biology seeks an Associate Research Scientist to be appointed as an Irving Cancer Early Scholar of Cancer Research. VISION The National Cancer Institute (NCI)-designated Herbert Irving Comprehensive Cancer Center (HICCC) of Columbia University Irving Medical Center invites applications for brilliant early career scientists to join a new program for Irving Cancer Early Scholars of Cancer Research. Initial appointments as Associate Research Scientists will be in the Department of Systems Biology for 3 years, after which Irving Cancer Early Scholars may seek tenure-track faculty positions at Columbia or other institutions. All assistant professor tenure track appointments require a national search and there will be no waiver from the Columbia University standard search process for individuals based on participation in this program. The HICCC hosts a vibrant community of highly-interactive investigators with interests in key areas of cancer research. We are now seeking new PhDs, MDs, or MD/PhDs to serve as Principal Investigators and fast‑track to faculty rank without the need to undertake a traditional postdoctoral fellowship. These Scholars will pursue creative experimental or computational approaches to cancer research in the basic, translational, clinical, and/or population sciences. GOALS/OBJECTIVES Irving Cancer Early Scholars will establish their independent program within a supporting laboratory and will be provided with all the resources necessary for success, including a dedicated mentorship committee of Columbia faculty, opportunities for pilot funding, collaboration with a wide range of Columbia scientists, and guidance in the preparation of grant applications as Principal Investigator. The recruitment package will include funds for salary and fringe benefits, research support and relocation costs. Housing support may also be available. As HICCC members, the Scholars will have access to superb HICCC Shared Resources and will join a vibrant community of clinicians and scientists across Columbia University and its affiliated institutions, including those working in cancer as well as in other areas. The Scholars will have demonstrated success (e.g. first/senior authored publications, awards, grants). Scholars will be expected to obtain grants from the NIH (e.g. DP4/DP5 through the Director’s office), foundations (e.g. Pew, Keck, Rita Allen, Buroughs-Welcome, Searle, etc) or other entities. We seek to identify the best and brightest and fast track them to faculty. For questions about research areas of interest and computational cancer research at Columbia and the HICCC, contact Dr. Raul Rabadan: View email address on click.appcast.io. For questions about eligibility and the application process, contact Dr. Emer Smyth: View email address on click.appcast.io. PhD, MD, or MD/PhD (or equivalent). Qualified Ph.D., MD or MD/Ph.D. (or equivalent) investigators should have demonstrated scientific productivity, evidenced by high-impact publications, and research momentum in computational biology with a vision to make an impactful contribution to cancer biology and cancer medicine. Interdisciplinary training (in quantitative sciences and/or medical sciences) is favored. Applicants should have recently completed their PhD or be in very early stages of postdoctoral research training. Doctoral students who are all but dissertation (ABD) and new Ph.D. graduates who are continuing with their mentor’s lab for a period of transition are also eligible. Individuals who are finishing or have recently completed clinical residency or fellowship training are also eligible to apply. Please upload the following: Curriculum Vitae; Research statement (2 pages); and Three (3) letters of reference. The HICCC is especially seeking applications from candidates from groups historically underrepresented in biomedical research. A steering committee will review applications submitted through a nationwide search that conforms with the requirements of the University’s policies on equal opportunity and affirmative action. Selected applicants will be invited for seminar/chalk talk presentations and interviews. A highly qualified candidate will be selected as the nominee. The Director of the HICCC in consultation with the Chair of Systems Biology will supervise and approve the selection before forwarding the nomination for review by the Dean, to ensure that the candidate has the proper qualifications and that the University’s policies governing affirmative action have been observed. Columbia University is an Equal Opportunity Employer / Disability / Veteran. Pay Transparency Disclosure The salary of the finalist selected for this role will be set based on a variety of factors, including but not limited to departmental budgets, qualifications, experience, education, licenses, specialty, and training. The above hiring range represents the University’s good faith and reasonable estimate of the range of possible compensation at the time of posting. #J-18808-Ljbffr